MAST - Magnesium for Sickle Cell Acute Crisis in Children
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if intravenous magnesium sulfate treatment is
effective in reducing the length of stay and pain in children with sickle cell disease
suffering an acute vaso-occlusive episode.